Effects of the individual isomers cis-9,trans-11 vs. trans-10,cis-12 of conjugated linoleic acid (CLA) on inflammation parameters in moderately overweight subjects with LDL-phenotype B

Lipids

Volumn 40, Issue 9, 2005, Pages 909-918

  Ramakers, Julian D ^a   Plat, Jogchum ^a   Sébédio, Jean Louis ^b   Mensink, Ronald P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; CHOLESTEROL; CYTOLOGY; DISEASE CONTROL; FATTY ACIDS; POLYSACCHARIDES; PROTEINS;

CONJUGATED LINOLEIC ACID (CLA); CYTOKINESIS; IMMUNE-MODULATING EFFECTS; PROTEIN EXPRESSION PATTERNS;

ISOMERS;

C REACTIVE PROTEIN; CHEMOKINE; CONJUGATED LINOLEIC ACID; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CELL STIMULATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; ISCHEMIC HEART DISEASE; ISOMER; MALE; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELLS, CULTURED; CHEMOKINE CCL2; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; ISOMERISM; LEUKOCYTES; LINOLEIC ACIDS, CONJUGATED; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OVERWEIGHT; PHENOTYPE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 27444435234     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-005-1451-8     Document Type: Article

References (38)

1. Pariza, M.W., and Ha, Y.L. (1990) Conjugated Dienoic Derivatives of Linoleic Acid: A New Class of Anticarcinogens, Med. Oncol Tumor Pharmacother. 7, 169-171.
2. Pariza, M.W., and Ha, Y.L. (1990) Conjugated Dienoic Derivatives of Linoleic Acid: Mechanism of Anticarcinogenic Effect, Prog. Clin. Biol. Res. 347, 217-221.
3. Kelley, D.S., and Erickson, K.L. (2003) Modulation of Body Composition and Immune Cell Functions by Conjugated Linoleic Acid in Humans and Animal Models: Benefits vs. Risks, Lipids 38, 377-386.
4. O'Shea, M., Bassaganya-Riera, J., and Mohede, I.C. (2004) Immunomodulatory Properties of Conjugated Linoleic Acid, Am. J. Clin. Nutr. 79, 1199S-1206S.
5. Tricon, S., Burdge, G.C., Kew, S., Banerjee, T., Russell, J.J., Grimble, R.F., Williams, C.M., Calder, P.C., and Yaqoob, P. (2004) Effects of cis-9,trans-11 and trans-10,cis-12 Conjugated Linoleic Acid on Immune Cell Function in Healthy Humans, Am. J. Clin. Nutr. 80, 1626-1633.
6. Yudkin, J.S., Kumari, M., Humphries, S.E., and Mohamed-Ali, V. (2000) Inflammation, Obesity, Stress and Coronary Heart Disease: Is Interleukin-6 the Link? Atherosclerosis 148, 209-214.
7. Austin, M.A., Breslow, J.L., Hennekens, C.H., Buring, J.E., Willett, W.C., and Krauss, R.M. (1988) Low-density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction, JAMA 260, 1917-1921.
8. Berneis, K.K., and Krauss, R.M. (2002) Metabolic Origins and Clinical Significance of LDL Heterogeneity, J. Lipid Res. 43, 1363-1379.
9. Krauss, R.M. (1995) Dense Low Density Lipoproteins and Coronary Artery Disease, Am. J. Cardiol. 75, 53B-57B.
10. Hansson, G.K. (2001) Immune Mechanisms in Atherosclerosis, Arterioscler. Thromb. Vasc. Biol. 21, 1876-1890.
11. Ross, R. (1999) Atherosclerosis-An Inflammatory Disease, N. Engl. J. Med. 340, 115-126.
12. Ridker, P.M., Rifai, N., Stampfer, M.J., and Hennekens, C.H. (2000) Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men, Circulation 101, 1767-1772.
13. Ridker, P.M., Hennekens, C.H., Buring, J.E., and Rifai, N. (2000) C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women, N. Engl. J. Med. 342, 836-843.
14. de Lemos, J.A., Morrow, D.A., Sabatine, M.S., Murphy, S.A., Gibson, C.M., Antman, E.M., McCabe, C.H., Cannon, C.P., and Braunwald, E. (2003) Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients with Acute Coronary Syndromes, Circulation 107, 690-695.
15. Malpuech-Brugere, C., Verboeket-Van De Venne, W.P., Mensink, R.P., Arnal, M.A., Morio, B., Brandolini, M., Saebo, A., Lassel, T.S., Chardigny, J.M., Sébédio, J.L., et al. (2004) Effects of Two Conjugated Linoleic Acid Isomers on Body Fat Mass in Overweight Humans, Obes. Res. 12, 591-598.
16. NEVO, S. (2001) NEVO Food Composition Table, The Netherlands Nutrient Databank 2001, The Hagne, NEVO Foundation.
17. Dentener, M.A., Bazil, V., Von Asmuth, E.J., Ceska, M., and Buurman, W.A. (1993) Involvement of CD14 in Lipopolysaccharide-Induced Tumor Necrosis Factor-Alpha, IL-6 and IL-8 Release by Human Monocytes and Alveolar Macrophages, J. Immunol. 150, 2885-2891.
18. Bouma, M.G., Stad, R.K., van den Wildenberg, F.A., and Buurman, W.A. (1994) Differential Regulatory Effects of Adenosine on Cytokine Release by Activated Human Monocytes, J. Immunol. 153, 4159-4168.
19. Engelberts, I., Moller, A., Schoen, G.J., van der Linden, C.J., and Buurman, W.A. (1991) Evaluation of Measurement of Human TNF in Plasma by ELISA, Lymphokine Cytokine Res. 10, 69-76.
20. Engelberts, I., Stephens, S., Francot, G.J., van der Linden, C.J., and Buurman, W. A. (1991) Evidence for Different Effects of Soluble TNF-Receptors on Various TNF Measurements in Human Biological Fluids, Lancet 338, 515-516.
21. Huddleston, D.J., Deitrick, C.L., Budrean, S.A., and Katholi, R.E. (2001) Performance Characteristics of an Automated Method for High-Sensitivity CRP on the Roche Cobas Mira Analyzer, Journal of the Association for Laboratory Automation 6, 32-33.
22. Plat, J., and Mensink, R.P. (2000) Vegetable Oil Based Versus Wood Based Stanol Ester Mixtures: Effects on Serum Lipids and Hemostatic Factors in Non-hypercholesterolemic Subjects, Atherosclerosis 148, 101-112.
23. Lins, R.L., Matthys, K.E., Billiouw, J.M., Dratwa, M., Dupont, P., Lameire, N.H., Peeters, P.C., Stolear, J.C., Tielemans, C., Maes, B., et al. (2004) Lipid and Apoprotein Changes During Atorvastatin Up-titration in Hemodialysis Patients with Hypercholesterolemia: A Placebo-Controlled Study, Clin. Nephrol. 62, 287-294.
24. Sébédio, J.L., Juaneda, P., Dobson, G., Ramilison, I., Martin, J.C., Chardigny, J.M., and Christie, W.W. (1997) Metabolites of Conjugated Isomers of Linoleic Acid (CLA) in the Rat, Biochim. Biophys. Acta 1345, 5-10.
25. Albers, R., van der Wielen, R.P., Brink, E.J., Hendriks, H.F., Dorovska-Taran, V.N., and Mohede, I.C. (2003) Effects of cis-9,trans-11 and trans-10,cis-12 Conjugated Linoleic Acid (CLA) isomers on Immune Function in Healthy Men, Eur. J. Clin. Nutr. 57, 595-603.
26. Kelley, D.S., Simon, V.A., Taylor, P.C., Rudolph, I.L., Benito, P., Nelson, G.J., Mackey, B.E., and Erickson, K.L. (2001) Dietary Supplementation with Conjugated Linoleic Acid Increased Its Concentration in Human Peripheral Blood Mononuclear Cells, but Did Not Alter Their Function, Lipids 36, 669-674.
27. Turek, J.J., Li, Y., Schoenlein, I.A., Allen, K.G.D., and Watkins, B.A. (1998) Modulation of Macrophage Cytokine Production by Conjugated Linoleic Acids Is Influenced by the Dietary n-6:n-3 Fatty Acid Ratio, J. Nutr. Biochem. 9, 258-266.
28. Kelley, D.S., Warren, J.M., Simon, V.A., Bartolini, G., Mackey, B.E., and Erickson, K.L. (2002) Similar Effects of c9,t11-CLA and t10,c-12-CLA on Immune Cell Functions in Mice, Lipids 37, 725-728.
29. Burdge, G.G., Lupoli, B., Russell, J.J., Tricon, S., Kew, S., Banerjee, T., Shingfield, K.J., Beever, D.E., Grimble, R.F., Williams, C.M., et al. (2004) Incorporation of cis-9,trans-11 or trans-10,cis-12 Conjugated Linoleic Acid into Plasma and Cellular Lipids in Healthy Men, J. Lipid Res. 45, 736-741.
30. Thijssen, M.A., Malpuech-Brugere, C., Gregoire, S., Chardigny, J.M., Sebedio, J.L., and Mensink, R.P. (2005) Effects of Specific CLA isomers on Plasma Fatty Acid Profile and Expression of Desaturases in Humans, Lipids 40, 137-145.
31. Risérus, U., Basu, S., Jovinge, S., Fredrikson, G.N., Ärnlöv, J., and Vessby, B. (2002) Supplementation with Conjugated Linoleic Acid Causes Isomer-Dependent Oxidative Stress and Elevated C-Reactive Protein: A Potential Link to Fatty Acid-Induced Insulin Resistance, Circulation 106, 1925-1929.
32. Christiansen, T., Richelsen, B., and Bruun, J.M. (2005) Monocyte Chemoattractant Protein-1 Is Produced in Isolated Adipocytes, Associated with Adiposity and Reduced After Weight Loss in Morbid Obese Subjects. Int. J. Obes. Relat. Metab. Disord. 29, 146-150.
33. Bruun, J.M., Pedersen, S.B., and Richelsen, B. (2001) Regulation of Interleukin 8 Production and Gene Expression in Human Adipose Tissue in vitro, J. Clin. Endocrinol. Metab. 86, 1267-1273.
34. Kelley, D.S., Taylor, P.C., Rudolph, I.L., Benito, P., Nelson, G.J., Mackey, B.E., and Erickson, K.L. (2000) Dietary Conjugated Linoleic Acid Did Not Alter Immune Status in Young Healthy Women, Lipids 35, 1065-1071.
35. Terpstra, A.H. (2004) Effect of Conjugated Linoleic Acid on Body Composition and Plasma Lipids in Humans: An Overview of the Literature, Am. J. Clin. Nutr. 79, 352-361.
36. Medina, E.A., Horn, W.F., Keim, N.L., Havel, P.J., Benito, P., Kelley, D.S., Nelson, G.J., and Erickson, K.L. (2000) Conjugated Linoleic Acid Supplementation in Humans: Effects on Circulating Leptin Concentrations and Appetite, Lipids 35, 783-788.
37. Risérus, U., Arner, P., Brismar, K., and Vessby, B. (2002) Treatment with Dietary trans10cis12 Conjugated Linoleic Acid Causes Isomer-Specific Insulin Resistance in Obese Men with the Metabolic Syndrome, Diabetes Care 25, 1516-1521.
38. Gaullier, J.M., Halse, J., Hoye, K., Kristiansen, K., Fagertun, H., Vik, H., and Gudmundsen, O. (2004) Conjugated Linoleic Acid Supplementation for 1 y Reduces Body Fat Mass in Healthy Overweight Humans, Am. J. Clin. Nutr. 79, 1118-1125.